Clinical trials
Transplant Complication clinical trials
Below are recruiting transplant complication clinical trials, each written for real people, not researchers. We’re tracking 122 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06236568Recruiting
Liver transplant study for liver cancer patients
This study tests a special way to preserve donated livers before transplant to see if it reduces the chance of liver cancer coming back after surgery.
Modena, MOAges 18 years+ - NCT04234139Enrolling by invitation
Study of severe alcoholic hepatitis patients before early liver transplant
This study follows people with severe alcoholic hepatitis who are being considered for an early liver transplant before they’ve been sober for 6 months. It aims to better understand this group’s situation and ethics/safety as early transplantation plans are made.
Baltimore, MarylandAges 18 years+ - NCT06808945Recruiting
Prehabilitation program for liver transplant patients
This study tests a pre-surgery exercise and nutrition program (prehabilitation) for people waiting for a liver transplant. It aims to see if getting stronger before surgery can help you recover better after the transplant.
RotterdamAges 18 years+ - NCT06257407Recruiting
Managing bleeding during and after liver transplant
This trial studies how doctors manage bleeding before, during, and after liver transplant surgery. The goal is to improve safety and outcomes for people receiving a new liver.
BesançonAges 18 years+ - NCT05950724Enrolling by invitationEarly Phase 1
TNF blocker to protect lungs after transplant
This early-stage trial tests whether blocking a specific inflammation signal (TNF-alpha) can help prevent or improve kidney problems and early graft (new lung) dysfunction after a lung transplant at Northwestern. You might be eligible if you’re scheduled for that transplant and are willing to go through study consent and follow-up.
Chicago, IllinoisAges 18 years+ - NCT06533592Recruiting
Bile duct connection technique in liver transplant
This study compares two ways of connecting the bile duct during a liver transplant to see which leads to a smoother recovery. It is for adults having a planned first transplant from a deceased donor.
Warsaw, Masovian VoivodeshipAges 18–75 - NCT07033858Recruiting
Short-term effects of Advograf plus Rapamiune after kidney transplant
This trial tests a combination of two medications (Advograf and Rapamiune) given shortly after kidney transplant to see how well they work and how safe they are. It may help improve long-term transplant health.
TehranAges 18 years+ - NCT05763446Recruiting
Predicting heavy blood transfusion during liver transplant
This study looks for factors that can predict when a person might need a very large blood transfusion during a liver transplant. The results may help the transplant team prepare sooner and better manage transfusions during surgery.
RomeAges 18 years+ - NCT04713774Recruiting
Tracking bone and blood vessel changes after kidney transplant
This study follows people who recently received a kidney transplant to see how bone strength and blood-vessel calcifications change over time. It may help doctors better understand what to monitor after transplant and how best to protect bone and heart health.
LiègeAges 18 years+ - NCT05242315RecruitingPhase 4
Long-acting tacrolimus after liver transplant
This trial studies whether taking an extended-release form of tacrolimus (a medicine to prevent transplant rejection) after a liver transplant works well for people who are followed at the University of Alberta. It may help simplify dosing and monitor safety and effectiveness after transplant.
Edmonton, AlbertaAges 18 years+ - NCT05679024RecruitingPhase 3
Apixaban to prevent stroke in atrial fibrillation and kidney failure
This trial tests apixaban (a blood thinner) to prevent stroke in people with atrial fibrillation or atrial flutter who have very poor kidney function or are on dialysis. If you qualify, you may help researchers find a safer way to lower stroke risk for this higher-risk group.
HelsinkiAges 18 years+ - NCT06104696Recruiting
Comprehensive Geriatric Assessment in Kidney Transplant Patients Over 60
This study looks at how a full health review (geriatric assessment) can help older adults who are getting or have gotten a new kidney. It aims to improve care and outcomes for patients aged 60 and over.
PragueAges 60 years+ - NCT06577805Recruiting
Robotic kidney transplant from living donors
This trial studies the results of kidney transplants using robotic surgery from living donors. It may help patients receive kidneys with potentially less impact from surgery.
Chengdu, SichuanAges 18–65 - NCT04246970Enrolling by invitation
Training program before and after liver transplant
This trial studies a structured exercise and training program before and after liver transplantation to help people recover better. You may be able to benefit if you’re getting an elective liver transplant and can safely participate in the training plan.
Valencia, ValenciaAges 18 years+ - NCT06782880Recruiting
Fecal transplant to prevent infections after liver transplant
This study tests if giving a fecal transplant (a procedure that transfers healthy bacteria from a donor's stool into your gut) before a liver transplant can lower the risk of serious infections after the surgery. It might help strengthen your immune system to fight off germs.
BolognaAges 18 years+ - NCT05526950Recruiting
Check cytokine filtration for people getting double lung transplants
This study tests a method during double lung transplant surgery to remove certain immune signals (“cytokines”) that may help the transplanted lungs heal. It’s only for adults who are having a planned double lung transplant at the study sites.
Lund, Skåne CountyAges 18–80 - NCT06386198Recruiting
Health Advocate for Young Liver Transplant Patients
This study tests a program that helps young adults with a liver transplant prepare to move from a children’s hospital to an adult hospital. It aims to provide extra support for people who also have social needs like trouble getting enough food.
San Francisco, CaliforniaAges 18–25 - NCT06512545Recruiting
Modified second stem cell transplant for graft failure
This study tests a modified second stem cell transplant for people whose first transplant failed. It uses half-matched (haploidentical) donor cells to try to restore healthy blood cells and treat the cancer.
Beijing, Beijing MunicipalityAges 14 years+ - NCT06512519Recruiting
Second stem cell transplant for graft failure
This trial tests a second transplant using a half-matched donor for people whose first transplant failed. It may help if you have a blood cancer and are otherwise healthy enough for another procedure.
Beijing, Beijing MunicipalityAges 14 years+ - NCT06603350Recruiting
How surgery factors affect recovery after lung transplant
This study looks at how things before, during, and right after lung transplant surgery affect recovery. Researchers want to learn what helps patients heal better so they can improve care.
Hangzhou, ZhejiangAges 18 years+ - NCT04469842RecruitingEarly Phase 1
Long-acting tacrolimus after lung transplant
This early-stage study tests a long-acting form of tacrolimus (a common anti-rejection medicine) soon after lung transplant. It aims to see if it can be used safely and effectively for people receiving lung transplants at Vanderbilt (VUMC).
Nashville, TennesseeAges 18 years+ - NCT06314230Recruiting
Genomics of chronic kidney transplant failure study
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
Westmead, New South WalesAges 18–75 - NCT06660095Enrolling by invitation
Measuring p50 during liver transplant surgery
This study is testing a new way to measure something called 'p50' during liver transplant surgery to see if it can help doctors better manage your care. It is for people who are having a planned liver transplant and are in relatively stable but serious health condition.
MalatyaAges 18–65 - NCT05708755RecruitingPhase 2
Monitoring immune response to CMV after lung transplant
This Phase 2 study monitors how your immune system reacts to CMV (a common virus) after a lung transplant. It may help doctors understand which patients are better protected and could guide future treatments to reduce CMV-related complications.
New York, New YorkAges 18–99
Hear when a new Transplant Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transplant complication?
- Yes. Clin2 currently lists 122 recruiting transplant complication studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transplant complication trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transplant complication trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.